Eileen Scully, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Investigator

Email:

escully1@jhmi.edu

Dr. Eileen Scully is an assistant professor of medicine at the Johns Hopkins University School of Medicine. 

She received her B.S. from the University of Notre Dame. She earned her Ph.D. and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital.

  • Protocol Chair, ACTG A5366
  • Investigator, Women's Health Inter-Network Scientific Committee (Dec 2017-Nov 2019)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More

A5361s: Pitavastatin to REduce Physical Function Impairment...

A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...

Read More